Provider Partnerships CompactCath's FDA and CE clearances enable hospital, DME, and home-health channel partnerships. As a small team, prioritizing distribution partnerships with DME networks and urology clinics can accelerate market penetration and patient access. This approach leverages existing care pathways to reach self-catheter users more effectively.

Direct Consumer Growth The product is consumer-facing with a discreet design and online presence, offering a path to scale via e-commerce, subscription models, and digital marketing. Investing in SEO, content, and patient education can drive online adoption and reduce friction for first-time users.

International Expansion CE clearance supports entry into European markets; expand through European distributors and clinics, while aligning with local reimbursement and regulatory requirements. This can broaden total addressable market beyond the US and leverage the CE stamp for credibility.

Unique Value Prop Pre-lubricated, non-touch design and compact form factor position CompactCath as a convenient option for active, self-catheterizing patients, a compelling differentiator versus standard catheters. Story built around Stanford origins enhances credibility in clinician and patient education materials to support adoption.

Strategic Partnerships With a small team and mid-range revenue, the company could benefit from strategic alliances with larger device manufacturers or contract manufacturers to scale production and distribution. Pursuing partnerships or investor funding can fuel expansion into new channels and geographies.